Linear displacement isothermal amplification method and application thereof
US-2024368679-A1 · Nov 7, 2024 · US
US10087482B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-10087482-B2 |
| Application number | US-86554109-A |
| Country | US |
| Kind code | B2 |
| Filing date | Feb 6, 2009 |
| Priority date | Feb 7, 2008 |
| Publication date | Oct 2, 2018 |
| Grant date | Oct 2, 2018 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present invention relates to a reaction mixture for the amplification of nucleic acids, the non-methylated cytosine bases of which have been converted to uracil bases by means of a bisulfition reaction. The invention also discloses methods for amplifying bisulfited nucleic acid and for determining the nucleic acid methylation state, and also kits based on the reaction mixture according to the invention.
Opening claim text (preview).
The invention claimed is: 1. A method for amplifying a bisulfite treated deoxyribose nucleic acid, comprising: a) contacting a bisulfite treated deoxyribose nucleic acid with at least one set of primers, at least one polymerase, dATP, dTTP, dCTP and dGTP, wherein the percent of the initial concentration of dATP and dTTP is 300% to 500% more than the initial concentration of dCTP and dGTP; and b) amplifying, with at least one polymerase, the bisulfite treated deoxyribose nucleic acid, wherein amplifying is carried out is carried out isothermally. 2. The method of claim 1 , wherein the bisulfite treated deoxyribose nucleic acid is contacted with at least one set of primers complementary to at least a portion of the sequence of the deoxyribose nucleic acid prior to bisulfite treatment or at least one set of primers complementary to at least a portion of the sequence of the bisulfite treated deoxyribose nucleic acid. 3. The method of claim 2 , wherein at least one set of primers is specific for at least one CpG island nucleic acid sequence, wherein the methylation state of the CpG island nucleic acid sequence is associated with a phenotype or a disease. 4. The method of claim 2 , wherein the bisulfite treated deoxyribose nucleic acid is contacted with between 5 and 250 sets of primers. 5. The method of claim 2 , wherein the bisulfite treated deoxyribose nucleic acid is contacted with more than 250 sets of primers. 6. The method of claim 1 , wherein the bisulfite treated deoxyribose nucleic acid is amplified in the presence of a ligase. 7. The method of claim 1 , wherein amplifying comprises RCA, MDA, or SDA. 8. The method of claim 1 , wherein the deoxyribose nucleic acid is genomic DNA or mitochondrial DNA.
Nucleic acid amplification reactions · CPC title
Strand displacement amplification [SDA] · CPC title
Concentration of a component of medium · CPC title
Bisulfite(s) · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.